Filing Details
- Accession Number:
- 0001562180-19-005412
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-08 17:01:28
- Reporting Period:
- 2019-11-06
- Accepted Time:
- 2019-11-08 17:01:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760185 | Patrick Trojer | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-06 | 195 | $4.08 | 8,417 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 801 | $5.51 | 9,218 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 8,641 | $5.51 | 17,859 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 18,765 | $5.62 | 36,624 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 5,786 | $7.60 | 42,410 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 839 | $7.60 | 43,249 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-06 | 2,893 | $8.04 | 46,142 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-06 | 11,535 | $20.01 | 34,607 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 23,072 | $25.06 | 11,535 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 11,535 | $30.16 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 2,893 | $0.00 | 2,893 | $8.04 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 839 | $0.00 | 839 | $7.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 5,786 | $0.00 | 5,786 | $7.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 18,765 | $0.00 | 18,765 | $5.62 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 8,641 | $0.00 | 8,641 | $5.51 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 801 | $0.00 | 801 | $5.51 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 195 | $0.00 | 195 | $4.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 43,387 | 2028-04-22 | No | 4 | M | Direct | |
| 850 | 2026-02-18 | No | 4 | M | Direct | |
| 40,494 | 2028-03-05 | No | 4 | M | Direct | |
| 2,836 | 2025-11-08 | No | 4 | M | Direct | |
| 17,312 | 2027-02-16 | No | 4 | M | Direct | |
| 3,121 | 2027-07-10 | No | 4 | M | Direct | |
| 0 | 2022-03-06 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This option was granted on July 11, 2017, and the shares underlying the options vest in equal quarterly installments through July 11, 2021.
- This option was granted on March 7, 2012, and is fully vested.
- This transaction was executed in multiple trades at prices ranging from $20.00 to $20.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.00to $25.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on April 23, 2018, and the shares underlying the options vest in equal quarterly installments through April 23, 2022.
- This option was granted on February 19, 2016, and the shares underlying the options vest in equal quarterly installments through February 19, 2020.
- This option was granted on March 6, 2018, and the shares underlying the options vest in equal quarterly installments through March 6, 2022.
- This option was granted on November 9, 2015, and is fully vested.
- This option was granted on February 17, 2017, and the shares underlying the options vest in equal quarterly installments through February 17, 2021.
Billionaire Hedge Funds
